Astrocyte ATP, Transmembrane Chemokine Drive Neuroprotection
whether any of this work relates to cells in their native context,” he told ARF.—Esther Landhuis None
373 RESULTS
You searched Landhuis
Sort By:
whether any of this work relates to cells in their native context,” he told ARF.—Esther Landhuis None
treatment, Holtzman told ARF.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3098
did not own. The patents at the center of this controversy expire next year.—Esther Landhuis. None
a Phase 3 AD trial (see ARF related news story).—Esther Landhuis None
Landhuis None http://www.alzforum.org/new/detail.asp?id=3269 Parkinson's Disease Research Models
Landhuis None http://www.alzforum.org/new/detail.asp?id=3282 Parkinson's Disease Genetics α-Synuclein
York Times story). The league also has a new website focusing on health and safety.—Esther Landhuis
meaningful analysis,” Zerr said.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=3402
phospho-tau (ARF news story on Cruchaga et al., 2013). —Esther Landhuis Q&A With Lawrence Steinman.
levels of inhibition.—Esther Landhuis. This is Part 2 of a three-part series. See also Part 1, Part 3.
non-convulsive epileptiform activity, Mucke reported.—Esther Landhuis. This is Part 3 of a three-part series.
reactivity may help identify AD patients early (see full comment below).—Esther Landhuis None
similar effects as Protollin.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3534
vivo.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3538 Alzheimer's Disease Immune
will appear in people, (see ARF conference story).—Esther Landhuis None